Trial Profile
Phase III registrational trial of pelareorep [Reolysin] in patients with muscle-invasive bladder cancer
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 12 Jun 2015
Price :
$35
*
At a glance
- Drugs Pelareorep (Primary)
- Indications Bladder cancer
- Focus Registrational; Therapeutic Use
- 12 Jun 2015 New trial record